Texas Public Policy Foundation Issues Statement on Proposed Drug Pricing Bill
September 24, 2019
September 24, 2019
AUSTIN, Texas, Sept. 24 -- Texas Public Policy Foundation issued the following statement by David Balat, director of right on health care, about proposed drug pricing bill (H.R. 3):
"The high costs of medication in this country are at a critical point for American families. Inflation-adjusted per capita spending on retail prescription drugs between 2013 and 2016 grew exponentially according to the Kaiser Family Foundation data. Research conducted by CVS has shown that 20% of Me . . .
"The high costs of medication in this country are at a critical point for American families. Inflation-adjusted per capita spending on retail prescription drugs between 2013 and 2016 grew exponentially according to the Kaiser Family Foundation data. Research conducted by CVS has shown that 20% of Me . . .